U.S. PHARMACOPEIA

Search USP29  
Methotrexate Tablets
» Methotrexate Tablets contain not less than 90.0 percent and not more than 110.0 percent of the labeled amount of methotrexate (C20H22N8O5).
Packaging and storage— Preserve in well-closed containers. A unit-of-use container contains a quantity of Tablets sufficient to provide one week's therapy as indicated in the labeling.
Labeling— When packaged in a unit-of-use container, the label indicates the total amount of methotrexate present as one week's supply.
Identification— Dissolve 1 Tablet in 100 mL of dilute hydrochloric acid (1 in 100), and filter the solution: the UV absorption spectrum of the filtrate exhibits maxima and minima at the same wavelengths as that of a solution containing about 2.5 mg of USP Methotrexate RS in 100 mL of dilute hydrochloric acid (1 in 100).
Dissolution 711
Medium: 0.1 N hydrochloric acid; 900 mL.
Apparatus 2: 50 rpm.
Time: 45 minutes.
Procedure— Determine the amount of C20H22N8O5 dissolved from UV absorbances at the wavelength of maximum absorbance at about 306 nm of filtered portions of the solution under test, suitably diluted with Dissolution Medium, in comparison with a Standard solution having a known concentration of USP Methotrexate RS in the same Medium.
Tolerances— Not less than 75% (Q) of the labeled amount of C20H22N8O5 is dissolved in 45 minutes.
Uniformity of dosage units 905: meet the requirements.
Residual solvents 467: meet the requirements.
(Official January 1, 2007)
Assay
pH 6.0 Buffer solution , Mobile phase, System suitability preparation, System suitability test, and Standard preparation—Proceed as directed in the Assay under Methotrexate.
Assay preparation— Weigh and finely powder not less than 20 Tablets. Weigh accurately a portion of the powder, equivalent to about 25 mg of methotrexate, and transfer to a 250-mL volumetric flask. Add about 200 mL of Mobile phase, and dissolve the methotrexate using a mechanical shaker or ultrasonic bath. Dilute with Mobile phase to volume, and mix.
Procedure— Proceed as directed for Procedure in the Assay under Methotrexate. Calculate the quantity, in mg, of methotrexate (C20H22N8O5) in the portion of Tablets taken by the formula:
250C(PU / PS),
in which C is the concentration, in mg per mL, of USP Methotrexate RS in the Standard preparation; and PU and PS are the peak responses obtained from the Assay preparation and the Standard preparation, respectively.
Auxiliary Information— Staff Liaison : Feiwen Mao, M.S., Senior Scientific Associate
Expert Committee : (MDOOD05) Monograph Development-Ophthalmics Oncologics and Dermatologicals
USP29–NF24 Page 1384
Phone Number : 1-301-816-8320